Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I).

Saved in:
Bibliographic Details
Title: Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I).
Authors: Gondry O; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium; odrade.gondry@uzbrussel.be.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Xavier C; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium., Raes L; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Heemskerk J; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Devoogdt N; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium., Everaert H; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Breckpot K; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., Lecocq Q; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., Decoster L; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Fontaine C; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Schallier D; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Aspeslagh S; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Vaneycken I; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Raes G; Cellular and Molecular Immunology, Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium; and.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium., Van Ginderachter JA; Cellular and Molecular Immunology, Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium; and.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium., Lahoutte T; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Caveliers V; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Keyaerts M; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Sep; Vol. 64 (9), pp. 1378-1384. Date of Electronic Publication: 2023 Jul 20.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-5667
DOI:10.2967/jnumed.122.264853